Form 4: Insider Buys at Boundless Bio
Insider Transaction Report
Director Kevin Tang acquired a significant number of Boundless Bio common shares through multiple transactions in late June and early July 2026.
Summary
- Director Kevin Tang, through various entities, acquired a total of 117,363 shares of Boundless Bio common stock between June 30, 2026, and July 2, 2026.
- These acquisitions were made at weighted-average prices ranging from $2.49 to $2.54 per share.
- Following these transactions, the total beneficial ownership of securities held indirectly by Tang Capital Partners, LP, Tang Capital Partners International, LP, Tang Capital Partners III, Inc., and Tang Capital Partners IV, Inc. increased.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a positive filing due to significant insider acquisition of shares by a director and 10% owner, indicating strong conviction.
Positives
- Significant insider buying activity by a director and 10% owner, indicating confidence in the company's prospects.
- Acquisition of shares at prices generally below $2.60, suggesting a potentially favorable entry point for the reporting person.
Future Outlook
No specific forward-looking statements or guidance were provided in this filing.
Industry Context
StockSavvy.ai notes that insider buying, particularly by directors and significant shareholders, is often interpreted as a positive signal by the market, suggesting a belief in the company's intrinsic value and future growth potential.
Stakeholder Impact
- Shareholders may view this insider buying as a positive indicator of management's confidence in the company's future performance.
Key Dates
| Date | Description |
|---|---|
| 06/30/2026 | Earliest transaction date reported. |
| 07/01/2026 | Transaction date for acquisition of 71,612 shares. |
| 07/02/2026 | Transaction date for acquisition of 9,821 shares and reporting person signature date. |
Recommendation
holdThe filing indicates significant insider buying, which is a positive signal. However, without broader financial performance data or strategic updates, a 'hold' recommendation is prudent, allowing for further analysis of the company's fundamentals and market position.
Keywords
Insider Trading, Form 4, Boundless Bio, BOLD, Common Stock, Director, 10% Owner, Securities Acquisition
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.